Virtus ETF Advisers LLC Replimune Group, Inc. Transaction History

Virtus ETF Advisers LLC

$234 Million
Q4 2024

A detailed history of Virtus ETF Advisers LLC transactions in Replimune Group, Inc. stock. As of the latest transaction made, Virtus ETF Advisers LLC holds 5,818 shares of REPL stock, worth $82,033. This represents 0.03% of its overall portfolio holdings.

Number of Shares

5,818

Previous 9,739 40.26%

Holding current value

$82,033

Previous $106,000 33.96%

% of portfolio

0.03%

Previous 0.05%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$10.54 - $14.93 $41,327 - $58,540	-3,921 Reduced 40.26%	5,818 $70,000
Q3 2024 Nov 14, 2024	BUY	$8.09 - $11.23 $1,375 - $1,909	170 Added 1.78%	9,739 $106,000
Q2 2024 Aug 14, 2024	SELL	$5.01 - $9.46 $7,995 - $15,098	-1,596 Reduced 14.29%	9,569 $86,000
Q1 2024 May 15, 2024	SELL	$6.87 - $9.31 $5,262 - $7,131	-766 Reduced 6.42%	11,165 $91,000
Q4 2023 Feb 15, 2024	BUY	$6.75 - $16.18 $52,076 - $124,828	7,715 Added 182.99%	11,931 $100,000
Q3 2023 Nov 07, 2023	SELL	$15.96 - $22.18 $6,623 - $9,204	-415 Reduced 8.96%	4,216 $72,000
Q2 2023 Aug 14, 2023	BUY	$15.65 - $24.1 $15,775 - $24,292	1,008 Added 27.82%	4,631 $107,000
Q1 2023 May 15, 2023	SELL	$17.48 - $29.09 $24,402 - $40,609	-1,396 Reduced 27.81%	3,623 $63,000
Q4 2022 Feb 14, 2023	SELL	$17.09 - $27.91 $36,470 - $59,559	-2,134 Reduced 29.83%	5,019 $136,000
Q3 2022 Nov 14, 2022	BUY	$15.6 - $21.15 $702 - $951	45 Added 0.63%	7,153 $124,000
Q2 2022 Aug 12, 2022	BUY	$13.32 - $19.98 $19,460 - $29,190	1,461 Added 25.87%	7,108 $124,000
Q1 2022 May 16, 2022	SELL	$15.24 - $29.75 $5,166 - $10,085	-339 Reduced 5.66%	5,647 $96,000
Q4 2021 Feb 14, 2022	SELL	$25.43 - $34.25 $3,763 - $5,069	-148 Reduced 2.41%	5,986 $162,000
Q3 2021 Nov 15, 2021	SELL	$28.98 - $39.54 $9,215 - $12,573	-318 Reduced 4.93%	6,134 $182,000
Q2 2021 Aug 10, 2021	SELL	$28.5 - $39.37 $12,397 - $17,125	-435 Reduced 6.32%	6,452 $248,000
Q1 2021 May 17, 2021	BUY	$30.22 - $45.57 $3,565 - $5,377	118 Added 1.74%	6,887 $210,000
Q4 2020 Feb 12, 2021	BUY	$23.5 - $52.65 $159,071 - $356,387	6,769 New	6,769 $258,000

Others Institutions Holding REPL

# of Institutions

158

Shares Held

76.1M

Call Options Held

40.6K

Put Options Held

53K

View Full List

About Replimune Group, Inc.

Ticker REPL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,306,700
Market Cap $695M
Description
Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes ...

More about REPL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtus ETF Advisers LLC with notifications on news.

Account

Virtus ETF Advisers LLC Replimune Group, Inc. Transaction History